Lentitek
Edinburgh · Founded 2019
About Lentitek
Lentitek is a cell and gene therapy company that is finding solutions to make exceptional cures available to more people. Lentitek is working on strategies to increase viral yield by tenfold or more.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: https://lentitek.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/lentitek-89812 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.